Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females (MEXISPATENT)

Mexis George

Status: Completed

Conditions: Androgenetic Alopecia

Treatments: Other: Hair loss prevention lotion

Study type: Interventional

Funder types: Other

Identifiers

NCT01701271

MEXIS-HAIR LOSS-STUDY 1.2012

Details and patient eligibility

About

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Androgenetic Alopecia.

Full description

This study verifies whether the tested product has any efficacy in the treatment of Androgenetic Alopecia.

• The evaluated product (Hair Loss prevention Lotion) is called:MEXIS, MPAF, M6S PATENT.

• 20 volunteers both men and women suffering from hair loss both in parties and over the entire scalp with age between 18 and 70 years have been selected for this test .

• Samples of the product have been applied following their usual use: as they are.

• On the selecting volunteers have been used:

  1. The pull test by pulling with fingers of some hair and counting them to estimate the evolution of the pathology.
  2. A sebum-meter to check the presence of scales on the scalp.
  3. A polarized light video-camera to check the redness of the scalp and to have a picture of hair and scalp.

• Volunteers were also asked about:

• Fluffiness

• Sheen

• Itching

• Presence of scales on scalp

• Oily hair

• Product's acceptability

• The readings are taken at 0 time (basal value), after 15 days (t15), 30 days (t30), 45 days (t45), 45 days (t45), 60 days (t60) and 90 days (t90) by the experimenter in the medical studio. Then they analyzed and reported in a graph.

• Summarizing tables and graphs of the data were taken during experimentation.

Enrollment: 20 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Good state of general health
• Suffering from hair loss
• No pharmacological treatment in progress
• Promise not to change the usual daily routine
• No atopy in the anamnesis

Exclusion criteria

• Illness
• Good state of hair
• Pharmacological treatment in progress
• Denial of the continuance of the usual daily routine
• Atopy in the anamnesis

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Volunteers

Experimental group

Description:

20 volunteers both men and women with an age between 18 and 70 years suffering from Androgenetic Allopecia in several types apply on the scalp drops of the hair loss prevention lotion

Treatment:

Other: Hair loss prevention lotion